Establishment and Composition. Within thirty (30) days of the Effective Date, the Parties shall establish an advisory committee (the “Committee”), with Corium having the right to appoint up to two (2) representatives on the Committee and ▇▇▇▇ having the right to appoint up to two (2) representatives. Such representatives shall include individuals within the management of each Party with expertise in drug development, regulatory, or accounting. Any member of the Committee may designate a substitute to attend and perform the functions of that member at any meeting of the Committee. Each Party may change its representatives so designated at any time at its sole discretion, by providing written notice to the other Party. ▇▇▇▇ shall designate one of its representatives as the chairperson for the Committee. The Committee shall serve as a monitoring and coordination body for the Program as needed and will attempt to agree on all matters related to the Program; however ▇▇▇▇ shall have the authority to make final decisions related to the Program.
Appears in 8 contracts
Sources: Development, Manufacturing and Commercialization Agreement, Development, Manufacturing and Commercialization Agreement, Development, Manufacturing and Commercialization Agreement (Corium International, Inc.)